nach oben

Erschienen in:

02.02.2016 | Chest

Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution

verfasst von: Gaël Dournes, Fanny Menut, Julie Macey, Michaël Fayon, Jean-François Chateil, Marjorie Salel, Olivier Corneloup, Michel Montaudon, Patrick Berger, François Laurent

Erschienen in: European Radiology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

We hypothesized that non-contrast-enhanced PETRA (pointwise encoding time reduction with radial acquisition) MR (magnetic resonance) sequencing could be an alternative to unenhanced computed tomography (CT) in assessing cystic fibrosis (CF) lung structural alterations, as well as compared agreements and concordances with those of conventional T1-weighted and T2-weighted sequences.

Material and methods

Thirty consecutive CF patients completed both CT and MRI the same day. No contrast injection was used. Agreement in identifying structural alterations was evaluated at the segmental level using a kappa test. Intraclass correlation coefficients (ICC) and Bland-Altman analysis were used to assess concordances and reproducibility in Helbich-Bhalla disease severity scoring.

Results

Agreement between PETRA and CT was higher than that of T1- or T2-weighted sequences, notably in assessing the segmental presence of bronchiectasis (Kappa = 0.83; 0.51; 0.49, respectively). The concordance in Helbich-Bhalla scores was very good using PETRA (ICC = 0.97), independently from its magnitude (mean difference (MD) = -0.3 [-2.8; 2.2]), whereas scoring was underestimated using both conventional T1 and T2 sequences (MD = -3.6 [-7.4; 0.1]) and MD = -4.6 [-8.2; -1.0], respectively). Intra- and interobserver reproducibility were very good for all imaging modalities (ICC = 0.86-0.98).

Conclusion

PETRA showed higher agreement in describing CF lung morphological changes than that of conventional sequences, whereas the Helbich-Bhalla scoring matched closely with that of CT.

Key Points

• Spatial resolution of lung MRI is limited using non-ultra-short TE MRI technique

• Ultra-short echo time (UTE) technique enables submillimeter 3D-MRI of airways

• 3D-UTE MRI shows very good concordance with CT in assessing cystic fibrosis

• Radiation-free 3D-UTE MRI enables the Helbich-Bhalla scoring without a need for contrast injection

Nur mit Berechtigung zugänglich

Jain M, Goss CH (2014) Update in cystic fibrosis 2013. Am J Respir Crit Care Med 189:1181–1186CrossRefPubMed

Kuehn BM (2014) Progress in treating cystic fibrosis means that many patients may now reach midlife and beyond. JAMA 312:1182–1183CrossRefPubMed

Loeve M, Krestin GP, Rosenfeld M, de Bruijne M, Stick SM, Tiddens HA (2013) Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease? Eur Respir J 42:844–857CrossRefPubMed

Bhalla M, Turcios N, Aponte V et al (1991) Cystic fibrosis: scoring system with thin-section CT. Radiology 179:783–788CrossRefPubMed

de Jong PA, Lindblad A, Rubin L et al (2006) Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 61:80–85CrossRefPubMed

O'Connor OJ, Vandeleur M, McGarrigle AM et al (2010) Development of low-dose protocols for thin-section CT assessment of cystic fibrosis in pediatric patients. Radiology 257:820–829CrossRefPubMed

Leuraud K, Richardson DB, Cardis E et al (2015) Ionising radiation and risk of death from leukaemia and lymphoma in radiation-monitored workers (INWORKS): an international cohort study. Lancet Haematol. doi:10.1016/S2352-3026(15)00094-0 PubMedCentral

Wielputz MO, Mall MA (2015) Imaging modalities in cystic fibrosis: emerging role of MRI. Curr Opin Pulm Med 21:609–616CrossRefPubMed

Altes TA, Eichinger M, Puderbach M (2007) Magnetic resonance imaging of the lung in cystic fibrosis. Proc Am Thorac Soc 4:321–327CrossRefPubMed

10.

Thomson LK, Thomson PC, Kingsmore DB et al (2014) Diagnosing nephrogenic systemic fibrosis in the post-FDA restriction era. J Magn Reson Imaging. doi:10.1002/jmri.24664 PubMed

11.

Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: Relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270:834–841CrossRefPubMed

12.

Tepper LA, Ciet P, Caudri D, Quittner AL, Utens EM, Tiddens HA (2015) Validating chest MRI to detect and monitor cystic fibrosis lung disease in a pediatric cohort. Pediatr Pulmonol. doi:10.1002/ppul.23328

13.

Eichinger M, Optazaite DE, Kopp-Schneider A et al (2012) Morphologic and functional scoring of cystic fibrosis lung disease using MRI. Eur J Radiol 81:1321–1329CrossRefPubMed

14.

Puderbach M, Eichinger M, Gahr J et al (2007) Proton MRI appearance of cystic fibrosis: comparison to CT. Eur Radiol 17:716–724CrossRefPubMed

15.

Renz DM, Scholz O, Bottcher J et al (2015) Comparison between magnetic resonance imaging and computed tomography of the lung in patients with cystic fibrosis with regard to clinical, laboratory, and pulmonary functional parameters. Invest Radiol. doi:10.1097/RLI.0000000000000178 PubMed

16.

Ciet P, Serra G, Bertolo S et al (2015) Assessment of CF lung disease using motion corrected PROPELLER MRI: a comparison with CT. Eur Radiol. doi:10.1007/s00330-015-3850-9 PubMed

17.

Sileo C, Corvol H, Boelle PY, Blondiaux E, Clement A, Ducou Le Pointe H (2014) HRCT and MRI of the lung in children with cystic fibrosis: comparison of different scoring systems. J Cyst Fibros 13:198–204CrossRefPubMed

18.

Johnson KM, Fain SB, Schiebler ML, Nagle S (2013) Optimized 3D ultrashort echo time pulmonary MRI. Magn Reson Med 70:1241–1250CrossRefPubMed

19.

Dournes G, Grodzki D, Macey J et al (2015) Quiet submillimeter MR imaging of the lung Is feasible with a PETRA sequence at 1.5 T. Radiology. doi:10.1148/radiol.15141655:141655 PubMed

20.

Ohno Y, Koyama H, Yoshikawa T et al (2015) Pulmonary high-resolution ultrashort TE MR imaging: comparison with thin-section standard- and low-dose computed tomography for the assessment of pulmonary parenchyma diseases. J Magn Reson Imaging. doi:10.1002/jmri.25008

21.

Helbich TH, Heinz-Peer G, Eichler I et al (1999) Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology 213:537–544CrossRefPubMed

22.

de Jong PA, Ottink MD, Robben SG et al (2004) Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 231:434–439CrossRefPubMed

23.

Kerem E, Conway S, Elborn S, Heijerman H, Consensus C (2005) Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 4:7–26CrossRefPubMed

24.

The Cystic Fibrosis Foundation Center Committee and Guidelines Subcommittee (1990). Cystic Fibrosis Foundation guidelines for patient services, evaluation, and monitoring in cystic fibrosis centers.. Am J Dis Child 144:1311–1312

25.

Wielputz MO, Heussel CP, Herth FJ, Kauczor HU (2014) Radiological diagnosis in lung disease: factoring treatment options into the choice of diagnostic modality. Dtsch Arztebl Int 111:181–187PubMedPubMedCentral

26.

Haute Autorité de Santé (2006) Mucoviscidose. Protocole National de Diagnostic et de Soins pour une Maladie Rare. Available via http://www.has-sante.fr/portail/jcms/c_464719/fr/ald-n18-mucoviscidose. Accessed 20 november 2015

27.

Loeve M, Lequin MH, de Bruijne M et al (2009) Cystic fibrosis: are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease? Radiology 253:223–229CrossRefPubMed

28.

Lee ES, Lee JM, Yu MH et al (2014) High spatial resolution, respiratory-gated, t1-weighted magnetic resonance imaging of the liver and the biliary tract during the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging. J Comput Assist Tomogr 38:360–366CrossRefPubMed

29.

Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246:697–722CrossRefPubMed

30.

Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed

31.

Burris NS, Johnson KM, Larson PE et al (2015) Detection of small pulmonary nodules with ultrashort echo time sequences in oncology patients by using a PET/MR system. Radiology. doi:10.1148/radiol.2015150489:150489 PubMed

32.

Bannas P, Bell LC, Johnson KM et al (2015) Pulmonary embolism detection with three-dimensional ultrashort echo time MR imaging: experimental study in canines. Radiology. doi:10.1148/radiol.2015150606:150606

33.

Grodzki DM, Jakob PM, Heismann B (2012) Ultrashort echo time imaging using pointwise encoding time reduction with radial acquisition (PETRA). Magn Reson Med 67:510–518CrossRefPubMed

34.

Bankier AA, De Maertelaer V, Keyzer C, Gevenois PA (1999) Pulmonary emphysema: subjective visual grading versus objective quantification with macroscopic morphometry and thin-section CT densitometry. Radiology 211:851–858CrossRefPubMed

35.

Ernst CW, Basten IA, Ilsen B et al (2014) Pulmonary disease in cystic fibrosis: assessment with chest CT at chest radiography dose levels. Radiology 273:597–605CrossRefPubMed

36.

Rosenow T, Oudraad MC, Murray CP et al (2015) PRAGMA-CF. A quantitative structural lung disease computed tomography outcome in young children with cystic fibrosis. Am J Respir Crit Care Med 191:1158–1165CrossRefPubMed

37.

Fink C, Puderbach M, Biederer J et al (2007) Lung MRI at 1.5 and 3 Tesla: observer preference study and lesion contrast using five different pulse sequences. Invest Radiol 42:377–383CrossRefPubMed

38.

Yan C, Tan X, Wei Q et al (2015) Lung MRI of invasive fungal infection at 3 Tesla: evaluation of five different pulse sequences and comparison with multidetector computed tomography (MDCT). Eur Radiol 25:550–557CrossRefPubMed

39.

Wielputz MO, Puderbach M, Kopp-Schneider A et al (2014) Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease. Am J Respir Crit Care Med 189:956–965CrossRefPubMed

40.

Maisonneuve P, Marshall BC, Knapp EA, Lowenfels AB (2013) Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States. J Natl Cancer Inst 105:122–129CrossRefPubMed

41.

Buzan MT, Eichinger M, Kreuter M et al (2015) T2 mapping of CT remodelling patterns in interstitial lung disease. Eur Radiol 25:3167–3174CrossRefPubMed

42.

Bryant M, Ley S, Eberhardt R et al (2015) Assessment of the relationship between morphological emphysema phenotype and corresponding pulmonary perfusion pattern on a segmental level. Eur Radiol 25:72–80CrossRefPubMed

Titel: Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution
verfasst von: Gaël Dournes
Fanny Menut
Julie Macey
Michaël Fayon
Jean-François Chateil
Marjorie Salel
Olivier Corneloup
Michel Montaudon
Patrick Berger
François Laurent
Publikationsdatum: 02.02.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 11/2016
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-016-4218-5

Neu im Fachgebiet Radiologie

23.04.2024 | Pankreaskarzinom | Nachrichten

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution

Abstract

Objectives

Material and methods

Results

Conclusion

Key Points

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie

Springer Medizin

Abstract

Objectives

Material and methods

Results

Conclusion

Key Points

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2016

Zebra sign of precentral gyri in amyotrophic lateral sclerosis: A novel finding using phase difference enhanced (PADRE) imaging-initial results

18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstruction

Balloon pulmonary angioplasty: applicability of C-Arm CT for procedure guidance

Feasibility of test-bolus DCE-MRI using CAIPIRINHA-VIBE for the evaluation of pancreatic malignancies

High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity

Preoperative axillary lymph node evaluation in breast cancer patients by breast magnetic resonance imaging (MRI): Can breast MRI exclude advanced nodal disease?

Neu im Fachgebiet Radiologie

S3-Leitlinie zu Pankreaskrebs aktualisiert

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Radiologie